Table 1.
The characteristics of the studied subjects in the present study (mean ± standard deviation).
| Colorectal cancer | Adenoma | Healthy controls | p-value | |
|---|---|---|---|---|
| No. of individuals | 71 | 63 | 91 | |
| Male (%) | 42 (59.15) | 34 (53.97) | 38 (41.76) | 0.07 |
| Age (years) | 61.85 ± 10.96 | 63.22 ± 7.29 | 60.23 ± 5.06 | 0.06 |
| BMI | 22.96 ± 3.85 | 23.81 ± 3.03 | 23.32 ± 1.97 | 0.11 |
| A/T/D/S/Ra | 16/5/2/8/40 | / | / | / |
| Stage I/II/III/IV | 9/30/27/5 | / | / | / |
| KRAS mutation (%) | 35 (49.3%) | / | / | / |
| CEA (ng/ml)b | 25.05 ± 14.52 | / | / | / |
| AFP (ng/ml) | 2.99 ± 1.22 | / | / | / |
| CA153 (U/ml) | 10.37 ± 4.66 | / | / | / |
| CA-125 (U/ml) | 16.98 ± 19.91 | / | / | / |
| CA199 (U/ml)b | 34.59 ± 15.38 | / | / | / |
| CA724 (U/ml)b | 6.68 ± 1.66 | / | / | / |
| CA50 (IU/ml)b | 16.30 ± 5.61 | / | / | / |
CEA, carcinoembryonic antigen; AFP, alpha-fetoprotein.
a
One patient had two cancers in both ascending colon and rectum, which was counted in both ascending colon cancer and rectal cancer: A, ascending colon; T, transversal colon; D, descending colon; S, sigmoid colon; R, rectum.
b
Mean ± standard error of mean (SEM).